Toxicity study of BCNU (NSC-409962) given orally.
D002330:Carmustine / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity*; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D002330:Carmustine